{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:11:28Z","timestamp":1792177888916,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T00:00:00Z","timestamp":1410480000000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jaip.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T20:01:13Z","timestamp":1379016073000},"page":"666-674.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Assessment of Antihistamine Use in Early Pregnancy and Birth Defects"],"prefix":"10.1016","volume":"1","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Werler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Ping","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2013.07.008_bib1","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Hardman","year":"2001"},{"key":"10.1016\/j.jaip.2013.07.008_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy","volume":"193","author":"Werler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2013.07.008_bib3","series-title":"Drugs in pregnancy and lactation","author":"Briggs","year":"2002"},{"key":"10.1016\/j.jaip.2013.07.008_bib4","series-title":"Pharmacoepidemiology","article-title":"Studies of drug-induced birth defects","author":"Mitchell","year":"2012"},{"key":"10.1016\/j.jaip.2013.07.008_bib5","first-page":"451","article-title":"First-trimester drug use and congenital disorders","volume":"65","author":"Aselton","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaip.2013.07.008_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0890-6238(95)00020-B","article-title":"Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen","volume":"9","author":"Brent","year":"1995","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaip.2013.07.008_bib7","first-page":"219","article-title":"Evaluation of an association between loratadine and hypospadias\u2014United States, 1997-2201","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2013.07.008_bib8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1067\/mai.2003.1499","article-title":"Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study","volume":"111","author":"Diav-Citrin","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.07.008_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1081-1206(10)63385-6","article-title":"Prospective controlled study of hydroxyzine and cetirizine in pregnancy","volume":"78","author":"Einarson","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2013.07.008_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7150\/ijms.3.106","article-title":"No increased risk of infant hypospadias after maternal use of loratadine in early pregnancy","volume":"3","author":"Kallen","year":"2006","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jaip.2013.07.008_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/tera.1420500105","article-title":"Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies","volume":"50","author":"McKeique","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.jaip.2013.07.008_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0890-6238(03)00108-4","article-title":"Effects of perinatal loratadine exposure on male rat reproductive organ development","volume":"17","author":"McIntyre","year":"2003","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaip.2013.07.008_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mai.2003.130","article-title":"Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study","volume":"111","author":"Moretti","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2013.07.008_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.1.5748.523","article-title":"Associations between drugs administered during pregnancy and congenital abnormalities of the fetus","volume":"1","author":"Nelson","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.jaip.2013.07.008_bib15","first-page":"258","article-title":"Pregnancy outcome after exposure to cetirizine\/levocetirizine in the first trimester\u2014a prospective controlled study","volume":"19","author":"Paulus","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaip.2013.07.008_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00045391-200607000-00008","article-title":"Prenatal exposure to loratadine in children with hypospadias: a nested case-control study within the Danish National Birth Cohort","volume":"13","author":"Pedersen","year":"2006","journal-title":"Am J Ther"},{"key":"10.1016\/j.jaip.2013.07.008_bib17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0041-008X(71)90243-2","article-title":"Teratogenesis studies with diphenhydramine HCl","volume":"18","author":"Schardein","year":"1971","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jaip.2013.07.008_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1081-1206(10)63382-0","article-title":"Antihistamines and pregnancy","volume":"78","author":"Schatz","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2013.07.008_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200831090-00006","article-title":"Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis","volume":"31","author":"Schwarz","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2013.07.008_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2007-994110","article-title":"Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis","volume":"14","author":"Seto","year":"1997","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jaip.2013.07.008_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9926(199801)57:1<1::AID-TERA1>3.0.CO;2-6","article-title":"Maternal illness, including fever and medication use as risk factors for neural tube defects","volume":"57","author":"Shaw","year":"1998","journal-title":"Teratology"},{"key":"10.1016\/j.jaip.2013.07.008_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.reprotox.2008.05.053","article-title":"The safety of cetirizine during pregnancy. A prospective observational cohort study","volume":"26","author":"Weber-Schoendorfer","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaip.2013.07.008_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","article-title":"Maternal medication use and risk of gastroschisis and small intestinal atresia","volume":"155","author":"Werler","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2013.07.008_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","article-title":"The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England","volume":"105","author":"Wilton","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaip.2013.07.008_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(74)93172-9","article-title":"Cleft palate and maternal diphenhydramine intake","volume":"1","author":"Saxen","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2013.07.008_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bdra.20513","article-title":"Use of antihistamine medications during early pregnancy and isolated major malformations","volume":"85","author":"Gilboa","year":"2009","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jaip.2013.07.008_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JRS-2001-263","article-title":"Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias?","volume":"14","author":"Kallen","year":"2001","journal-title":"Int J Risk Saf Med"},{"key":"10.1016\/j.jaip.2013.07.008_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/jmf.11.3.146.152","article-title":"Use of antihistamine drugs in early pregnancy and delivery outcome","volume":"11","author":"Kallen","year":"2002","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jaip.2013.07.008_bib29","series-title":"Birth Defects and Drugs in Pregnancy","author":"Heinonen","year":"1977"},{"key":"10.1016\/j.jaip.2013.07.008_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/096032718300200105","article-title":"Maternal anti-nauseants and clefts of lip and palate","volume":"2","author":"Golding","year":"1983","journal-title":"Hum Toxicol"},{"key":"10.1016\/j.jaip.2013.07.008_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.aje.a113887","article-title":"Pyloric stenosis and maternal Bendectin exposure","volume":"120","author":"Aselton","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2013.07.008_bib32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0002-9378(82)90185-5","article-title":"Bendectin (Debendox) as a risk factor for pyloric stenosis","volume":"144","author":"Eskenazi","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2013.07.008_bib33","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.1981.03310470025020","article-title":"Birth defects related to Bendectin use in pregnancy. I. Oral clefts and cardiac defects","volume":"245","author":"Mitchell","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2013.07.008_bib34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jama.1993.03500100055027","article-title":"Periconceptional folic acid exposure and risk of occurrent neural tube defects","volume":"269","author":"Werler","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2013.07.008_bib35","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2013.07.008_bib36","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2012.12.023","article-title":"Safety of macrolides during pregnancy","volume":"208","author":"Lin","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2013.07.008_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/pds.2234","article-title":"Drug certainty-response in interview-based studies","volume":"20","author":"Yau","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2013.07.008_bib38","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1440-1681.1998.tb02179.x","article-title":"Multiple comparison procedures updated","volume":"25","author":"Ludbrook","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jaip.2013.07.008_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc Series B"},{"key":"10.1016\/j.jaip.2013.07.008_bib40","first-page":"66","article-title":"Measuring drug effectiveness by default: the case of Bendectin","volume":"86","author":"Neutel","year":"1995","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jaip.2013.07.008_bib41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0002-9378(83)90028-5","article-title":"Birth defects in relation to Bendectin use in pregnancy. II. Pyloric stenosis","volume":"147","author":"Mitchell","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2013.07.008_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5694\/j.1326-5377.1985.tb122871.x","article-title":"The creation of therapeutic orphans\u2014or, what have we learnt from the Debendox fiasco?","volume":"143","author":"Sheffield","year":"1985","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaip.2013.07.008_bib43","unstructured":"U.S. Food and Drug Administration. FDA News release. FDA approves Diclegis for pregnant women experiencing nausea and vomiting, April 8, 2013. Available from: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm347087.htm. Accessed August 6, 2013."},{"key":"10.1016\/j.jaip.2013.07.008_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/oxfordjournals.aje.a115145","article-title":"Reporting accuracy among mothers of malformed and nonmalformed infants","volume":"129","author":"Werler","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2013.07.008_bib45","series-title":"Pharmacoepidemiology","first-page":"750","article-title":"Special considerations in studies of drug-induced birth defects","author":"Mitchell","year":"2000"},{"key":"10.1016\/j.jaip.2013.07.008_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/oxfordjournals.aje.a113335","article-title":"Etiologic heterogeneity of neural tube defects: clues from epidemiology","volume":"115","author":"Khoury","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2013.07.008_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.pap.0000201831.77472.d3","article-title":"Renal cystic diseases: a review","volume":"13","author":"Bisceglia","year":"2006","journal-title":"Adv Anat Pathol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219813003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219813003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:05:46Z","timestamp":1761973546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219813003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213219813003024"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2013.07.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Antihistamine Use in Early Pregnancy and Birth Defects","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}